Sema~Glutide
Sema~Glutide
Jumlah
Pesanan minimum adalah: 1 boxPengiriman
Pemasok akan mengirim dalam 2–10 hari setelah pembayaran dikonfirmasi.
Barang akan dikirim dari United Kingdom pelabuhan.
Pengiriman ditawarkan dengan syarat FOB — pemasok menanggung biaya ke pelabuhan pengiriman yang ditentukan.
Pembayaran: Western Union
Sampel tersedia · $200.00/per sampel
Euromart Suppliers perlindungan pesanan
Setiap pembayaran Anda diamankan dengan enkripsi SSL ketat dan protokol perlindungan data PCI DSS
Lakukan pengembalian lokal gratis untuk produk cacat pada pembelian yang memenuhi syarat
Klaim pengembalian dana jika pesanan tidak dikirim, hilang, atau tiba dengan masalah produk
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
KEY FEATURES
Therapeutic Class: GLP‑1 receptor agonist (peptide therapy)
Primary Uses: Type 2 diabetes management, chronic weight management
Mechanism of Action :
Stimulates insulin secretion when glucose is elevated
Reduces glucagon release
Slows gastric emptying → appetite suppression
Clinical Benefits :
Proven HbA1c reduction
Average 10-15% weight loss during trial
Cardiovascular protection (reduced risk of heart attack/stroke in diabetic patients)
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (semaglutide)
Dosage forms :
Injection pens: 0.25 mg, 0.5 mg, 1 mg, 2 mg (weekly dosing)
Oral tablets: 3 mg, 7 mg, 14 mg (daily dosing)
Brands/Models:
Ozempic® – Weekly injection pen for type 2 diabetes
Wegovy® – Weekly injection pen for weight management
Rybelsus® – Daily oral tablet for type 2 diabetes
Storage & Handling :
Injection pens: Refrigerate until first use; room temperature up to 56 days after opening
Tablets: Store at room temperature, away from moisture
Safety profile :
Common side effects: Nausea, diarrhea, constipation
Serious risks: Pancreatitis, gallbladder issues, kidney problems, rare thyroid tumors
Contraindications: Type 1 diabetes, pregnancy, breastfeeding, history of medullary thyroid carcinoma or MEN2
AVAILABLE CONFIGURATIONS
Format and Delivery :
Prefilled injection pens (fixed strengths)
Oral tablets (daily dosing)
Compounded vials (for specialized clinical supply)
Concerntration & Dosing:
Branded pens: fixed strengths (0.25–2 mg)
Oral tablets: fixed strengths (3–14 mg)
Custom compounding: adjustable concentrations for research or clinical customization
Packaging & Lebeling:
Bulk API shipments
Finished product packaging (retail-ready)
Private labeling / white‑label options for distributors
Shipping and Compliance :
Cold chain logistics available
Flexible Incoterms (FOB, CIF, DAP, DDP)
Documentation tailored to HS code classification and regulatory requirements
GB
